| New tumour entities in the 4th edition of the World Health Organization Classification of Head and Neck tumours: odontogenic and maxillofacial bone tumours |
31 |
| Deep learning for automatic Gleason pattern classification for grade group determination of prostate biopsies |
27 |
| Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms |
26 |
| The new TNM-based staging of breast cancer |
24 |
| The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer |
22 |
| Adoptive cellular therapies: the current landscape |
21 |
| Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations |
18 |
| High immune cell score predicts improved survival in pancreatic cancer |
17 |
| Precision immunoprofiling by image analysis and artificial intelligence |
17 |
| Gut microbiome: a new player in gastrointestinal disease |
15 |
| A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal |
15 |
| Validation of the Oncomine((TM)) focus panel for next-generation sequencing of clinical tumour samples |
15 |
| Immunohistochemical analysis and prognostic significance of PD-L PD- and CD8+tumor-infiltrating lymphocytes in Ewing's sarcoma family of tumors (ESFT) |
15 |
| Eighth Edition of the UICC Classification of Malignant Tumours: an overview of the changes in the pathological TNM classification criteria-What has changed and why? |
14 |
| Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphoma |
13 |
| Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy |
13 |
| Machine learning approaches for pathologic diagnosis |
12 |
| High-grade oncocytic renal tumor: morphologic, immunohistochemical, and molecular genetic study of 14 cases |
12 |
| Recent advances in the histological and molecular classification of endometrial stromal neoplasms |
11 |
| The landscape of genetic alterations in ameloblastomas relates to clinical features |
11 |
| IQN path ASBL report from the first European cfDNA consensus meeting: expert opinion on the minimal requirements for clinical ctDNA testing |
11 |
| The performance of digital microscopy for primary diagnosis in human pathology: a systematic review |
10 |
| New tumor entities in the 4th edition of the World Health Organization classification of head and neck tumors: Nasal cavity, paranasal sinuses and skull base |
10 |
| RUSSCO-RSP comparative study of immunohistochemistry diagnostic assays for PD-L1 expression in urothelial bladder cancer |
10 |
| Misses and near misses in diagnosing nodular fasciitis and morphologically related reactive myofibroblastic proliferations: experience of a referral center with emphasis on frequency of USP6 gene rearrangements |
10 |
| Local vs. systemic pulmonary amyloidosis-impact on diagnostics and clinical management |
10 |
| Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm |
9 |
| Interobserver variability in the H&E-based assessment of tumor budding in pT3/4 colon cancer: does it affect the prognostic relevance? |
9 |
| Recent success and limitations of immune checkpoint inhibitors for cancer: a lesson from melanoma |
9 |
| Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study |
9 |
| Pathology of idiopathic non-cirrhotic portal hypertension |
9 |
| PD-L1 receptor expression in vulvar carcinomas is HPV-independent |
9 |
| Invited review-next-generation sequencing: a modern tool in cytopathology |
9 |
| The role of epithelial-mesenchymal transition in squamous cell carcinoma of the oral cavity |
9 |
| Evaluation of the budding and depth of invasion (BD) model in oral tongue cancer biopsies |
9 |
| Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics |
9 |
| c-MYC amplification and c-myc protein expression in pancreatic acinar cell carcinomas. New insights into the molecular signature of these rare cancers |
8 |
| State of the art in post-mortem computed tomography: a review of current literature |
8 |
| Impact of delayed and prolonged fixation on the evaluation of immunohistochemical staining on lung carcinoma resection specimen |
8 |
| Regression of human cirrhosis: an update, 18 years after the pioneering article by Wanless et al. |
8 |
| Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine |
8 |
| The spectrum of myocarditis: from pathology to the clinics |
8 |
| beta-Catenin nuclear expression discriminates deep penetrating nevi from other cutaneous melanocytic tumors |
8 |
| Impact of delayed fixation and decalcification on PD-L1 expression: a comparison of two clones |
8 |
| Pathologic significance of AKT, mTOR, and GSK3 beta proteins in oral squamous cell carcinoma-affected patients |
8 |
| Immune checkpoint inhibitor colitis: the flip side of the wonder drugs |
8 |
| Machine learning application for prediction of locoregional recurrences in early oral tongue cancer: a Web-based prognostic tool |
8 |
| Low-grade endometrial stromal sarcoma with a novel MEAF6-SUZ12 fusion |
7 |
| Extra-axial chordoma: a clinicopathologic analysis of six cases |
7 |
| Disease activity and mucosal healing in inflammatory bowel disease: a new role for histopathology? |
7 |
